50
Participants
Start Date
January 1, 2024
Primary Completion Date
March 1, 2024
Study Completion Date
September 1, 2024
Mesoglycan
Mesoglycan capsules 50 mg are composed by heparan sulphate 47.5%, dermathan sulphate 35.5%, chondroitin sulfate 8.5%,slow heparin 8.5%, excipients: lactose monohydrate, corn starch, croscarmellose sodium, magnesium stearate, gelatin, titanium dioxide, erythrosine
Placebo
placebo capsules are composed by lactose monohydrate, corn starch, croscarmellose sodium, magnesium stearate
Neopharmed Gentili S.p.A.
INDUSTRY
Societa Italiana di Chirurgia ColoRettale
NETWORK